Why the study?
How does estrogen status affect the renin-angiotensin-aldosterone system and blood pressure in women?
How does estrogen status affect the renin-angiotensin-aldosterone system and blood pressure in women?
This review proposes that estrogen deficiency in premenopausal women with functional hypothalamic amenorrhea alters RAAS activity, contrasting with the increased RAAS activity seen in postmenopausal estrogen deficiency.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for RAAS effects of premenopausal estrogen deficiency; leaves open contrast with postmenopausal patterns and clinical relevance.
The renin-angiotensin-aldosterone system (RAAS) is integrally involved in multiple cardiovascular physiological processes including arterial blood pressure (BP) regulation. Over activity of the RAAS has been implicated in the pathogenesis of a number of cardiovascular disease entities, including hypertension. Several lines of evidence suggest estrogen favorably modulates the RAAS. Conversely, estrogen deficiency due to menopause may contribute to over activity of the RAAS. Of importance, estrogen deficiency in women is not exclusive to the postmenopausal period. Functional hypothalamic amenorrhea is a reversible cause of premenopausal hypoestrogenemia. In contrast to postmenopausal women (PMW), premenopausal women with exercise-associated functional hypothalamic amenorrhea demonstrate decreased, not increased, resting BP compared with their estrogen-replete eumenorrheic counterpart. In this review we briefly examine the effects of estrogen status on the RAAS and present the hypothesis that the RAAS is altered in physically active women with functional hypothalamic amenorrhea.
No takes yet. Share an insight, caveat, or question.
O’Donnell et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: